Cytological Assessment of Donor-Site Healing After Free Gingival Grafting
Cytological Evaluation of the Effects of Different Donor-Site Interventions on Healing After Free Gingival Graft Surgery
An adequate width of keratinized gingiva is important for maintaining periodontal and peri-implant tissue health. Free gingival grafting (FGG) is a commonly performed surgical procedure for increasing insufficient keratinized gingival width. This study aims to evaluate the effect of applying a chitosan sponge to the palatal donor site on wound healing after FGG using exfoliative cytology and to compare the findings with those obtained from a control group in which no chitosan sponge is applied.
At least 40 patients scheduled to undergo FGG because of insufficient keratinized gingival width will be included. The patients will be allocated to two groups: a test group and a control group. In the test group, a chitosan sponge will be applied to the palatal donor site, whereas no wound dressing will be applied to the palatal donor site in the control group. The primary outcome will be the keratinization index determined from cytological samples collected from the palatal donor site at one month after surgery. The keratinization index values at one month will be compared between the test and control groups.
All participants will receive detailed information about the study and the procedures, and written informed consent will be obtained. Clinical measurements will be recorded before surgery, after which the FGG procedure will be performed. Depending on group allocation, the palatal donor site will either be treated with a chitosan sponge or left without a wound dressing. Sutures will be removed on postoperative day 10.
For exfoliative cytological assessment, baseline samples will be collected from both the planned palatal donor site and the contralateral symmetrical healthy palatal site, which will not undergo surgery, in all patients. Samples collected from the symmetrical palatal site will serve as a reference for the baseline characteristics of healthy palatal mucosa. Follow-up samples will be collected exclusively from the palatal donor site on postoperative day 3,10 and at 1, 3, and 6 months. The keratinization index and other cellular features associated with wound healing will be assessed in the cytological samples. Findings obtained during the follow-up periods will be compared between the test group treated with a chitosan sponge and the control group in which no wound dressing is applied. In addition, the presence or absence of sensory loss at the palatal donor site will be evaluated using a periodontal probe.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Istanbul, Turquía (Türkiye)
- Reclutamiento
- Biruni University
-
Contacto:
- Ayşe Ege Selman
- Número de teléfono: 902124448276
- Correo electrónico: ayseegeselman@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Volunteering to participate in the study,
- Being at least 18 years of age,
- The need for SDG in patients with < 2 mm of keratinized gingiva on the vestibular side of the implant/tooth,
- No prior surgical procedures or grafts in the palatal region,Volunteering to participate in the study,
Exclusion Criteria:
- The presence of a systemic disease that would contraindicate surgical treatment,
- Uncontrolled diabetes (HbA1c > 7),
- Pregnancy or breastfeeding,
- Autoimmune and/or inflammatory diseases of the oral cavity,
- Active periodontal disease.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Comparador activo: Control
|
Free gingival graft surgery |
|
Experimental: Prueba
|
Free gingival graft surgery Suturing of chitosan sponge to the palatal donor site |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Palatal donor site tissue thickness:
Periodo de tiempo: Pre-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
Pre-operative
|
|
Palatal donor site tissue thickness:
Periodo de tiempo: immediate Post-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
immediate Post-operative
|
|
Palatal donor site tissue thickness:
Periodo de tiempo: day 10
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 10
|
|
Palatal donor site tissue thickness:
Periodo de tiempo: day 30
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 30
|
|
Palatal donor site tissue thickness:
Periodo de tiempo: day 90
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 90
|
|
Palatal donor site tissue thickness:
Periodo de tiempo: day 180
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 180
|
|
Keratinization Index
Periodo de tiempo: day 3
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Keratinization Index
Periodo de tiempo: day 10
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Keratinization Index
Periodo de tiempo: day 30
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Keratinization Index
Periodo de tiempo: day 90
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Keratinization Index
Periodo de tiempo: day 180
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
|
Superficial cell index
Periodo de tiempo: day 3
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Superficial cell index
Periodo de tiempo: day 10
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Superficial cell index
Periodo de tiempo: day 30
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Superficial cell index
Periodo de tiempo: day 90
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Superficial cell index
Periodo de tiempo: day 180
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Loss of sensation
Periodo de tiempo: Day 10
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 10
|
|
Loss of sensation
Periodo de tiempo: Day 30
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 30
|
|
Loss of sensation
Periodo de tiempo: Day 90
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 90
|
|
Loss of sensation
Periodo de tiempo: Day 180
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 180
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
Otros números de identificación del estudio
- 2015-KAEK-80-23-44
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .